- Organization Overview
- Dean’s Office
- Dean’s Office Overview
- PharmD Education Unit
- Office of Faculty Academic Affairs
- Office of Administration
- Pharmacy Practice Partnerships
- Department of Bioengineering and Therapeutic Sciences
- Department of Clinical Pharmacy
- Department of Pharmaceutical Chemistry
- Quantitative Biosciences Institute
- Org Chart
- Patient Care
Krogan elected to the European Molecular Biology Organization
By UCSF School of Pharmacy Editorial Staff / Mon Jul 11, 2022
Nevan Krogan, PhD, was elected to the European Molecular Biology Organization (EMBO) as an associate member on July 6. He is one of 67 researchers to be inducted into the prestigious organization this year, joining Europe's premier outlet for advancing scientific discovery.
Krogan, director of the UCSF School of Pharmacy’s Quantitative Biosciences Institute (QBI), received this honor in recognition of his outstanding achievements in the life sciences. He is best known for using quantitative approaches to study proteins and their roles in human health and disease. His work frequently brings together a cross-section of institutions and disciplines to tackle diseases caused by viruses like Zika, HIV, and SARS.
Krogan’s work also recently led to the award of the largest federal research grant in UCSF’s history, aimed at applying quantitative approaches to fight the current pandemic and prepare for future ones.
EMBO touts a community of more than 1,900 leading scientists from a wide variety of fields, including cell biology, cancer, vaccine development, and machine learning.
“It’s an honor to be included in this brilliant group of scientists,” said Krogan. “I have great hopes that this award will facilitate more European collaborations, which are essential in helping us understand diseases and a path to their solutions.”
About the School: The UCSF School of Pharmacy aims to solve the most pressing health care problems and strives to ensure that each patient receives the safest, most effective treatments. Our discoveries seed the development of novel therapies, and our researchers consistently lead the nation in NIH funding. The School’s doctor of pharmacy (PharmD) degree program, with its unique emphasis on scientific thinking, prepares students to be critical thinkers and leaders in their field.